Aggiornamento
Contraccezione in adolescenza
Contraception in adolescence
Cecilia Bonin, Valentino Clignon
UOC di Ostetricia e Ginecologia B, AOUI di Verona
Novembre 2020 - pagg. 562 -568 | DOI: 10.53126/MEB39562
Abstract
Modern contraceptives are very effective when correctly used and, thus, effective counselling regarding contraceptive options are key components of adolescent health care. Emergency contraception should routinely be included in discussions about contraception. Among the many methods available on the market, long-acting reversible contraceptives have higher efficacy, higher continuation rates and higher satisfaction rates compared with short-acting contraceptives among the adolescents who choose to use them.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Ganchimeg T, Ota E, Morisaki N, et al. Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study. BJOG 2014;121 Suppl 1:40-8.
2. PLAN international Italia, 2019. https:// www.plan-international.it.
3. Imamura M, Tucker J, Hannaford P, et al. Factors associated with teenage pregnancy in the European Union countries: a systematic review. Eur J Public Health 2007;17(6):630-6.
4. De Nisi M, Bianchi L, Piffer S. Gravidanze e nascite nelle adolescenti. Analisi del fenomeno. Anni 2000-2005. Osservatorio epidemiologico italiano, giugno 2008, pag. 7-8.
5. UNFPA. Adolescent Pregnancy. A review of the evidence 2013.
6. Albizzati A, Ierardi E, Moioli M, Riva Crugnola C. Profilo psicopatologico e di rischio psicosociale in madri adolescenti e di giovane età nel postpartum. Medico e Bambino 2020;39(7):445-51.
7. [No Authors listed] ACOG Committee opinion no. 735: Adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2018;131 (5):e130-9.
8. Dean G, Schwarz EB (eds). Intrauterine contraception. New York: Ardent Media; 2011.
9. Todd N, Black A. Contraception for adolescents. J Clin Res Pediatr Endocrinol 2020; 12(Suppl 1):28-40.
10. Hatcher RA, Trussell J, Nelson AL, Cates WJ, Kowal D, Policar MS. Contraceptive technology. 20th rev. New York (NY): Ardent Media Ed, 2011.
11. Bahamondes L, Diaz J, Marchi NM, Petta CA, Cristofoletti ML, Gomez G. Performance of copper intrauterine devices when inserted after an expulsion. Human Reproduction 1995;10:2917-8.
12. Mansour D, Gemzell-Danielsson K, Inki P. Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception 2011;84(5):465.
13. Morrell K. Long-acting reversible contraception in adolescents. J Pediatr Adolesc Gynecol 2012;25(6):407-9.
14. Pfizer. Depo-Provera contraceptive injection (medroxyprogesterone acetate injec-table suspension). 2011.
15. Merck & Co. Nexplanon prescribing information.
16. Committee on Adolescent Health Care. Committee opinion no 699 - Adolescent pregnancy, contraception, and sexual activity. Obstet Gynecol 2017;129(5):e142-9.
17. Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011-2018. National Health Stat Report 2018;104:1-23.
18. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006-2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49(1):7-16.
19. Diedrich JT, Klein DA, Peipert JF. Long acting reversible contraception in adolescent: a sistematic review and meta-analysis. Am J Obstet Gynecol 2017;216(4):364.e1-e12.
20. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203(2):115.e1-e7.
21. American College of Obstetricians and Gynecologists. Immediate postpartum long-acting reversible contraception. Obstet Gynecol 2016;670:128-32.
22. Polit DF, Kahn JR. Early subsequent pregnancy among economically disadvantaged teenage mothers. Am J Public Health 1986;76(2):167-71.
23. Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group. Practice bulletin no. 186 - Long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2017; 130(5):251-69.
24. Lopez LM, Bernholc A, Zeng Y, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2015; (7):CD007373.
25. https://www.gazzettaufficiale.it/eli/ id/2020/10/10/20A05497/sg
26. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis [published correction appears in Lancet 2014;384 (9953):1504]. Lancet 2010;375(9714):555-62.
27. Chernick LS, Chun TH, Richards R, et al.; Pediatric Emergency Care Applied Research Network (PECARN). Sex without contraceptives in a multicenter study of adolescent Emergency Department patients. Acad Emerg Med 2020;27(4):283-90.
28. Kortsmit K, Williams L, Pazol K, et al. Condom use with long-acting reversible contraception vs non-long-acting reversible contraception hormonal methods among postpartum adolescents. JAMA Pediatr 2019;173 (7):663-70.
29. Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorestrel implant for contraception: a randomized, multicentre, open label trial. Lancet 2019;394:303-13.
30. Newton VL, Dickson J, Hoggart L. Young women’s fertility knowledge: partial knowledge and implications for contraceptive risk-taking. BMJ Sex Reprod Health 2020;46(2): 147-51.
Corrispondenza: cecilia.bonin@aovr.veneto.it